+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global HPV Testing and Pap Test Market By Type, By Application, By Product, By End Use, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

  • ID: 5354454
  • Report
  • June 2021
  • Region: Global
  • 259 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Abbott Laboratories
  • Arbor Vita Corporation
  • F. Hoffmann-La Roche Ltd.
  • Femasys, Inc.
  • Hologic, Inc.
  • Qiagen N.V.

The Global HPV Testing and Pap Test Market size is expected to reach $7.1 billion by 2027, rising at a market growth of 33.5% CAGR during the forecast period. Pap tests and HPV Testing both are included in cervical cancer screening which is a crucial part of a woman’s routine health checkup as it can discover cancer of abnormalities that could result in cancer of the cervix. It is suggested that a woman should undergo a Pap test every 3 years starting from the age of 21. Also, it is further recommended that women between the ages of 30 to 65 should undergo Pap and HPV every after 5 years or a Pap test in 3 years. Women having some risk factors may require more often screening or to keep on screening themselves even after the age of 65 years.

Some of the determinants that boost the demand & growth of HPV testing and Pap test are constant technological developments, a rising number of cervical cancer screening programs, and growing cases of cervical cancer. On the other hand, the global COVID-19 crisis and the imposition of various lockdown norms and restrictions to keep people in their homes have substantially decreased routine cancer screenings.



COVID-19 Impact

Interruptions in cancer screening services have been observed in a majority of settings as a result of the global coronavirus crisis. Guidelines for cancer screening activities are generally created after systematic and careful consideration of the optimally available evidence to provide high-quality care and to cut down variability in clinical practice. Though, the beginning of the COVId-19 pandemic needed an instant response at a time when the duration of the pandemic could not be predicted and the nature of the virus was still majorly unidentified. In the majority of settings, the consequence of this situation was a time-restricted deferment of services. These disturbances are anticipated to cause highly advanced cancer diagnoses and deaths in the next few years.

Screening services have now restarted to some extent in most of the countries; though, subsequent the deadly COVId-19 outbreak continues to create disruption in healthcare provisions. In spite of the approval of different secure and extremely effective COVID-19 vaccines, supply constraints have deferred their roll-out. Hence, the present disruptions to health care, in general, are expected to remain the same for some time. Therefore, the outbreak of COVID-19 pandemic has adversely affected the HPV testing and Pap test market.

Type Outlook

Based on Type, the market is segmented into Pap Test and HPV Testing. The Pap test segment procured the maximum revenue share of the global HPV testing and Pap test in 2020. This is credited to its large-scale implementation in various screening programs. In addition to it, the segment is expected to witness a boost with the increasing number of initiatives to raise awareness regarding Pap tests.

Application Outlook

Based on Application, the market is segmented into Cervical Cancer Screening, and Vaginal Cancer Screening. In 2020, the cervical cancer screening segment appeared as the leading segment in the HPV testing and Pap test market by obtaining the highest revenue share. The segment is expected to exhibit a promising CAGR during the forecast period. This growth and massive revenue share are credited to the increasing rates of cervical cancer in comparison to vaginal cancer.

Product Outlook

Based on Product, the market is segmented into Consumables, Instruments, and Services. The consumables segment acquired the highest revenue share of the HPV testing and Pap test market, thereby became a dominant segment in 2020. This is credited to its high and constant utilization in HPV and cervical screenings. Besides, the growth of the segment is expected to be accelerated by the constant development activities by leading players in the market and the launch of unique consumables, like assays & kits, for high accuracy of diagnosis in HPV and Pap test.



End Use Outlook

Based on End Use, the market is segmented into Hospitals & Clinics, Laboratories and Other End Users. The hospitals and clinics segment obtained the maximum revenue share of the HPV testing and Pap test market and thus, became the leading segment in 2020. This is credited to the fact that they act as primary care settings for diagnosis and treatment of all diseases, such as HPV infections and cervical cancer. In addition to it, the requirement for hospitals and clinics with superior diagnostic services has been boosted by a surge in healthcare spending around the globe and constant modification in the healthcare industry.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America emerged as the leading region in the global HPV testing and Pap test market by acquiring the maximum revenue share of it. The region is expected to exhibit a similar trend even during the forecast period. Some of the catalysts for the growth of the regional market are increasing awareness regarding the early diagnosis of cervical cancer, well-planned screening guidelines, and supportive healthcare reimbursement policies.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Hologic, Inc., Quest Diagnostics, Incorporated, Seegene, Inc., Arbor Vita Corporation, Femasys, Inc., and Qiagen N.V.

Strategies deployed in HPV Testing and Pap Test Market

Nov-2020: Hologic got CE mark in Europe for its Genius Digital Diagnostics System. It is the first digital cytology platform that integrates a new artificial intelligence (AI) algorithm with advanced digital imaging for helping cytotechnologists and pathologists identify pre-cancerous lesions and cancer cells in women.

Sep-2020: BD submitted the pre-market approval (PMA) supplement to the U.S. Food and Drug Administration (FDA). It is used for the ThinPrep Pap Test PreservCyt Solution vial as an approved sample type for its BD Onclarity HPV Assay. The PMA supplement aims to expand the sample claims, which can be used with the BD SurePath vial for the detection of human papillomavirus (HPV) using the BD Onclarity HPV Assay.

Apr-2020: Roche received US Food and Drug Administration (FDA) approval for cobas HPV test. This test is used on the fully automated, high-throughput cobas 6800/8800 Systems. The test recognizes the women at risk for cervical cancer by detecting the presence of high-risk human papillomavirus (HPV) DNA in cervical samples.

Mar-2020: Roche got US Food and Drug Administration (FDA) approval of CINtec PLUS Cytology. It is a first biomarker-based triage test for women whose primary cervical cancer screening results are positive for the human papillomavirus (HPV) using the cobas 4800 HPV Test.

Apr-2018: Hologic announced that the United States Food and Drug Administration (FDA) provided the premarket approval (PMA) for the ThinPrep Integrated Imager. This imager aims to make automated imaging of Pap tests more broadly available to laboratories and cytologists in the United States.

Feb-2018: BD got pre-market approval from the U.S. Food and Drug Administration (FDA) for the BD Onclarity HPV assay. This test discovers 14 types of high-risk human papillomavirus (HPV) from specimens collected for cervical cancer screening ("Pap test") in the BD SurePath liquid based cytology vial.

Apr-2017: Roche announced the launch of the Cobas HPV assay. This assay is used on the Cobas 6800 and Cobas 8800 systems for the screening of cervical cancer in countries accepting the CE mark.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Pap Test
  • HPV Testing

By Application

  • Cervical Cancer Screening,
  • Vaginal Cancer Screening

By Product

  • Consumables
  • Instruments,
  • Services

By End Use

  • Hospitals & Clinics
  • Laboratories
  • Other End Users

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Quest Diagnostics, Incorporated
  • Seegene, Inc.
  • Arbor Vita Corporation
  • Femasys, Inc.
  • Qiagen N.V.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Arbor Vita Corporation
  • F. Hoffmann-La Roche Ltd.
  • Femasys, Inc.
  • Hologic, Inc.
  • Qiagen N.V.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global HPV Testing And PAP Test Market, by Type
1.4.2 Global HPV Testing And PAP Test Market, by Application
1.4.3 Global HPV Testing And PAP Test Market, by Product
1.4.4 Global HPV Testing And PAP Test Market, by End Use
1.4.5 Global HPV Testing And PAP Test Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario:
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
2.2.3 Market Opportunity

Chapter 3. Global HPV Testing And Pap Test Market by Type
3.1 Global Pap Test Market by Region
3.2 Global HPV Testing Market by Region

Chapter 4. Global HPV Testing And Pap Test Market by Application
4.1 Global Cervical Cancer Screening Market by Region
4.2 Global Vaginal Cancer Screening Market by Region

Chapter 5. Global HPV Testing And Pap Test Market by Product
5.1 Global Consumables Market by Region
5.2 Global Instruments Market by Region
5.3 Global Services Market by Region

Chapter 6. Global HPV Testing And Pap Test Market by Technology
6.1 Global PCR Market by Region
6.2 Global Immunodiagnostics Market by Region
6.3 Global Other Technologies Market by Region

Chapter 7. Global HPV Testing And Pap Test Market by End Use
7.1 Global Hospitals & Clinics Market by Region
7.2 Global Laboratories Market by Region
7.3 Global Other End Use Market by Region

Chapter 8. Global HPV Testing And Pap Test Market by Region
8.1 North America HPV Testing And Pap Test Market
8.1.1 North America HPV Testing And Pap Test Market by Type
8.1.1.1 North America Pap Test Market by Country
8.1.1.2 North America HPV Testing Market by Country
8.1.2 North America HPV Testing And Pap Test Market by Application
8.1.2.1 North America Cervical Cancer Screening Market by Country
8.1.2.2 North America Vaginal Cancer Screening Market by Country
8.1.3 North America HPV Testing And Pap Test Market by Product
8.1.3.1 North America Consumables Market by Country
8.1.3.2 North America Instruments Market by Country
8.1.3.3 North America Services Market by Country
8.1.4 North America HPV Testing And Pap Test Market by Application
8.1.4.1 North America PCR Market by Country
8.1.4.2 North America Immunodiagnostics Market by Country
8.1.4.3 North America Other Technologies Market by Country
8.1.5 North America HPV Testing And Pap Test Market by End Use
8.1.5.1 North America Hospitals & Clinics Market by Country
8.1.5.2 North America Laboratories Market by Country
8.1.5.3 North America Other End Uses Market by Country
8.1.6 North America HPV Testing And Pap Test Market by Country
8.1.6.1 US HPV Testing And Pap Test Market
8.1.6.1.1 US HPV Testing And Pap Test Market by Type
8.1.6.1.2 US HPV Testing And Pap Test Market by Application
8.1.6.1.3 US HPV Testing And Pap Test Market by Product
8.1.6.1.4 US HPV Testing And Pap Test Market by Technology
8.1.6.1.5 US HPV Testing And Pap Test Market by End Use
8.1.6.2 Canada HPV Testing And Pap Test Market
8.1.6.2.1 Canada HPV Testing And Pap Test Market by Type
8.1.6.2.2 Canada HPV Testing And Pap Test Market by Application
8.1.6.2.3 Canada HPV Testing And Pap Test Market by Product
8.1.6.2.4 Canada HPV Testing And Pap Test Market by Technology
8.1.6.2.5 Canada HPV Testing And Pap Test Market by End Use
8.1.6.3 Mexico HPV Testing And Pap Test Market
8.1.6.3.1 Mexico HPV Testing And Pap Test Market by Type
8.1.6.3.2 Mexico HPV Testing And Pap Test Market by Application
8.1.6.3.3 Mexico HPV Testing And Pap Test Market by Product
8.1.6.3.4 Mexico HPV Testing And Pap Test Market by Technology
8.1.6.3.5 Mexico HPV Testing And Pap Test Market by End Use
8.1.6.4 Rest of North America HPV Testing And Pap Test Market
8.1.6.4.1 Rest of North America HPV Testing And Pap Test Market by Type
8.1.6.4.2 Rest of North America HPV Testing And Pap Test Market by Application
8.1.6.4.3 Rest of North America HPV Testing And Pap Test Market by Product
8.1.6.4.4 Rest of North America HPV Testing And Pap Test Market by Technology
8.1.6.4.5 Rest of North America HPV Testing And Pap Test Market by End Use
8.2 Europe HPV Testing And Pap Test Market
8.2.1 Europe HPV Testing And Pap Test Market by Type
8.2.1.1 Europe Pap Test Market by Country
8.2.1.2 Europe HPV Testing Market by Country
8.2.2 Europe HPV Testing And Pap Test Market by Application
8.2.2.1 Europe Cervical Cancer Screening Market by Country
8.2.2.2 Europe Vaginal Cancer Screening Market by Country
8.2.3 Europe HPV Testing And Pap Test Market by Product
8.2.3.1 Europe Consumables Market by Country
8.2.3.2 Europe Instruments Market by Country
8.2.3.3 Europe Services Market by Country
8.2.4 Europe HPV Testing And Pap Test Market by Technology
8.2.4.1 Europe PCR Market by Country
8.2.4.2 Europe Immunodiagnostics Market by Country
8.2.4.3 Europe Other Technology Market by Country
8.2.5 Europe HPV Testing And Pap Test Market by End Use
8.2.5.1 Europe Hospitals & Clinics Market by Country
8.2.5.2 Europe Laboratories Market by Country
8.2.5.3 Europe Other End Uses Market by Country
8.2.6 Europe HPV Testing And Pap Test Market by Country
8.2.6.1 Germany HPV Testing And Pap Test Market
8.2.6.1.1 Germany HPV Testing And Pap Test Market by Type
8.2.6.1.2 Germany HPV Testing And Pap Test Market by Application
8.2.6.1.3 Germany HPV Testing And Pap Test Market by Product
8.2.6.1.4 Germany HPV Testing And Pap Test Market by Technology
8.2.6.1.5 Germany HPV Testing And Pap Test Market by End Use
8.2.6.2 UK HPV Testing And Pap Test Market
8.2.6.2.1 UK HPV Testing And Pap Test Market by Type
8.2.6.2.2 UK HPV Testing And Pap Test Market by Application
8.2.6.2.3 UK HPV Testing And Pap Test Market by Product
8.2.6.2.4 UK HPV Testing And Pap Test Market by Technology
8.2.6.2.5 UK HPV Testing And Pap Test Market by End Use
8.2.6.3 France HPV Testing And Pap Test Market
8.2.6.3.1 France HPV Testing And Pap Test Market by Type
8.2.6.3.2 France HPV Testing And Pap Test Market by Application
8.2.6.3.3 France HPV Testing And Pap Test Market by Product
8.2.6.3.4 France HPV Testing And Pap Test Market by Technology
8.2.6.3.5 France HPV Testing And Pap Test Market by End Use
8.2.6.4 Russia HPV Testing And Pap Test Market
8.2.6.4.1 Russia HPV Testing And Pap Test Market by Type
8.2.6.4.2 Russia HPV Testing And Pap Test Market by Application
8.2.6.4.3 Russia HPV Testing And Pap Test Market by Product
8.2.6.4.4 Russia HPV Testing And Pap Test Market by Technology
8.2.6.4.5 Russia HPV Testing And Pap Test Market by End Use
8.2.6.5 Spain HPV Testing And Pap Test Market
8.2.6.5.1 Spain HPV Testing And Pap Test Market by Type
8.2.6.5.2 Spain HPV Testing And Pap Test Market by Application
8.2.6.5.3 Spain HPV Testing And Pap Test Market by Product
8.2.6.5.4 Spain HPV Testing And Pap Test Market by Technology
8.2.6.5.5 Spain HPV Testing And Pap Test Market by End Use
8.2.6.6 Italy HPV Testing And Pap Test Market
8.2.6.6.1 Italy HPV Testing And Pap Test Market by Type
8.2.6.6.2 Italy HPV Testing And Pap Test Market by Application
8.2.6.6.3 Italy HPV Testing And Pap Test Market by Product
8.2.6.6.4 Italy HPV Testing And Pap Test Market by Technology
8.2.6.6.5 Italy HPV Testing And Pap Test Market by End Use
8.2.6.7 Rest of Europe HPV Testing And Pap Test Market
8.2.6.7.1 Rest of Europe HPV Testing And Pap Test Market by Type
8.2.6.7.2 Rest of Europe HPV Testing And Pap Test Market by Application
8.2.6.7.3 Rest of Europe HPV Testing And Pap Test Market by Product
8.2.6.7.4 Rest of Europe HPV Testing And Pap Test Market by Technology
8.2.6.7.5 Rest of Europe HPV Testing And Pap Test Market by End Use
8.3 Asia Pacific HPV Testing And Pap Test Market
8.3.1 Asia Pacific HPV Testing And Pap Test Market by Type
8.3.1.1 Asia Pacific Pap Test Market by Country
8.3.1.2 Asia Pacific HPV Testing Market by Country
8.3.2 Asia Pacific HPV Testing And Pap Test Market by Application
8.3.2.1 Asia Pacific Cervical Cancer Screening Market by Country
8.3.2.2 Asia Pacific Vaginal Cancer Screening Market by Country
8.3.3 Asia Pacific HPV Testing And Pap Test Market by Product
8.3.3.1 Asia Pacific Consumables Market by Country
8.3.3.2 Asia Pacific Instruments Market by Country
8.3.3.3 Asia Pacific Services Market by Country
8.3.4 Asia Pacific HPV Testing And Pap Test Market by Technology
8.3.4.1 Asia Pacific PCR Market by Country
8.3.4.2 Asia Pacific Immunodiagnostics Market by Country
8.3.4.3 Asia Pacific Other Application HPV Testing And Pap Test Market by Country
8.3.5 Asia Pacific HPV Testing And Pap Test Market by End Use
8.3.5.1 Asia Pacific Hospitals & Clinics Market by Country
8.3.5.2 Asia Pacific Laboratories Market by Country
8.3.5.3 Asia Pacific Other End Uses Market by Country
8.3.6 Asia Pacific HPV Testing And Pap Test Market by Country
8.3.6.1 China HPV Testing And Pap Test Market
8.3.6.1.1 China HPV Testing And Pap Test Market by Type
8.3.6.1.2 China HPV Testing And Pap Test Market by Application
8.3.6.1.3 China HPV Testing And Pap Test Market by Product
8.3.6.1.4 China HPV Testing And Pap Test Market by Technology
8.3.6.1.5 China HPV Testing And Pap Test Market by End Use
8.3.6.2 Japan HPV Testing And Pap Test Market
8.3.6.2.1 Japan HPV Testing And Pap Test Market by Type
8.3.6.2.2 Japan HPV Testing And Pap Test Market by Application
8.3.6.2.3 Japan HPV Testing And Pap Test Market by Product
8.3.6.2.4 Japan HPV Testing And Pap Test Market by Technology
8.3.6.2.5 Japan HPV Testing And Pap Test Market by End Use
8.3.6.3 India HPV Testing And Pap Test Market
8.3.6.3.1 India HPV Testing And Pap Test Market by Type
8.3.6.3.2 India HPV Testing And Pap Test Market by Application
8.3.6.3.3 India HPV Testing And Pap Test Market by Product
8.3.6.3.4 India HPV Testing And Pap Test Market by Application
8.3.6.3.5 India HPV Testing And Pap Test Market by End Use
8.3.6.4 South Korea HPV Testing And Pap Test Market
8.3.6.4.1 South Korea HPV Testing And Pap Test Market by Type
8.3.6.4.2 South Korea HPV Testing And Pap Test Market by Application
8.3.6.4.3 South Korea HPV Testing And Pap Test Market by Product
8.3.6.4.4 South Korea HPV Testing And Pap Test Market by Application
8.3.6.4.5 South Korea HPV Testing And Pap Test Market by End Use
8.3.6.5 Singapore HPV Testing And Pap Test Market
8.3.6.5.1 Singapore HPV Testing And Pap Test Market by Type
8.3.6.5.2 Singapore HPV Testing And Pap Test Market by Application
8.3.6.5.3 Singapore HPV Testing And Pap Test Market by Product
8.3.6.5.4 Singapore HPV Testing And Pap Test Market by Technology
8.3.6.5.5 Singapore HPV Testing And Pap Test Market by End Use
8.3.6.6 Malaysia HPV Testing And Pap Test Market
8.3.6.6.1 Malaysia HPV Testing And Pap Test Market by Type
8.3.6.6.2 Malaysia HPV Testing And Pap Test Market by Application
8.3.6.6.3 Malaysia HPV Testing And Pap Test Market by Product
8.3.6.6.4 Malaysia HPV Testing And Pap Test Market by Technology
8.3.6.6.5 Malaysia HPV Testing And Pap Test Market by End Use
8.3.6.7 Rest of Asia Pacific HPV Testing And Pap Test Market
8.3.6.7.1 Rest of Asia Pacific HPV Testing And Pap Test Market by Type
8.3.6.7.2 Rest of Asia Pacific HPV Testing And Pap Test Market by Application
8.3.6.7.3 Rest of Asia Pacific HPV Testing And Pap Test Market by Product
8.3.6.7.4 Rest of Asia Pacific HPV Testing And Pap Test Market by Technology
8.3.6.7.5 Rest of Asia Pacific HPV Testing And Pap Test Market by End Use
8.4 LAMEA HPV Testing And Pap Test Market
8.4.1 LAMEA HPV Testing And Pap Test Market by Type
8.4.1.1 LAMEA Pap Test Market by Country
8.4.1.2 LAMEA HPV Testing Market by Country
8.4.2 LAMEA HPV Testing And Pap Test Market by Application
8.4.2.1 LAMEA Cervical Cancer Screening Market by Country
8.4.2.2 LAMEA Vaginal Cancer Screening Market by Country
8.4.3 LAMEA HPV Testing And Pap Test Market by Product
8.4.3.1 LAMEA Consumables Market by Country
8.4.3.2 LAMEA Instruments Market by Country
8.4.3.3 LAMEA Services Market by Country
8.4.4 LAMEA HPV Testing And Pap Test Market by Technology
8.4.4.1 LAMEA PCR Market by Country
8.4.4.2 LAMEA Immunodiagnostics Market by Country
8.4.4.3 LAMEA Other Technologies Market by Country
8.4.5 LAMEA HPV Testing And Pap Test Market by End Use
8.4.5.1 LAMEA Hospitals & Clinics Market by Country
8.4.5.2 LAMEA Laboratories Market by Country
8.4.5.3 LAMEA Other End Uses Market by Country
8.4.6 LAMEA HPV Testing And Pap Test Market by Country
8.4.6.1 Brazil HPV Testing And Pap Test Market
8.4.6.1.1 Brazil HPV Testing And Pap Test Market by Type
8.4.6.1.2 Brazil HPV Testing And Pap Test Market by Application
8.4.6.1.3 Brazil HPV Testing And Pap Test Market by Product
8.4.6.1.4 Brazil HPV Testing And Pap Test Market by Technology
8.4.6.1.5 Brazil HPV Testing And Pap Test Market by End Use
8.4.6.2 Argentina HPV Testing And Pap Test Market
8.4.6.2.1 Argentina HPV Testing And Pap Test Market by Type
8.4.6.2.2 Argentina HPV Testing And Pap Test Market by Application
8.4.6.2.3 Argentina HPV Testing And Pap Test Market by Product
8.4.6.2.4 Argentina HPV Testing And Pap Test Market by Technology
8.4.6.2.5 Argentina HPV Testing And Pap Test Market by End Use
8.4.6.3 UAE HPV Testing And Pap Test Market
8.4.6.3.1 UAE HPV Testing And Pap Test Market by Type
8.4.6.3.2 UAE HPV Testing And Pap Test Market by Application
8.4.6.3.3 UAE HPV Testing And Pap Test Market by Product
8.4.6.3.4 UAE HPV Testing And Pap Test Market by Technology
8.4.6.3.5 UAE HPV Testing And Pap Test Market by End Use
8.4.6.4 Saudi Arabia HPV Testing And Pap Test Market
8.4.6.4.1 Saudi Arabia HPV Testing And Pap Test Market by Type
8.4.6.4.2 Saudi Arabia HPV Testing And Pap Test Market by Application
8.4.6.4.3 Saudi Arabia HPV Testing And Pap Test Market by Product
8.4.6.4.4 Saudi Arabia HPV Testing And Pap Test Market by Technology
8.4.6.4.5 Saudi Arabia HPV Testing And Pap Test Market by End Use
8.4.6.5 South Africa HPV Testing And Pap Test Market
8.4.6.5.1 South Africa HPV Testing And Pap Test Market by Type
8.4.6.5.2 South Africa HPV Testing And Pap Test Market by Application
8.4.6.5.3 South Africa HPV Testing And Pap Test Market by Product
8.4.6.5.4 South Africa HPV Testing And Pap Test Market by Technology
8.4.6.5.5 South Africa HPV Testing And Pap Test Market by End Use
8.4.6.6 Nigeria HPV Testing And Pap Test Market
8.4.6.6.1 Nigeria HPV Testing And Pap Test Market by Type
8.4.6.6.2 Nigeria HPV Testing And Pap Test Market by Application
8.4.6.6.3 Nigeria HPV Testing And Pap Test Market by Product
8.4.6.6.4 Nigeria HPV Testing And Pap Test Market by Technology
8.4.6.6.5 Nigeria HPV Testing And Pap Test Market by End Use
8.4.6.7 Rest of LAMEA HPV Testing And Pap Test Market
8.4.6.7.1 Rest of LAMEA HPV Testing And Pap Test Market by Type
8.4.6.7.2 Rest of LAMEA HPV Testing And Pap Test Market by Application
8.4.6.7.3 Rest of LAMEA HPV Testing And Pap Test Market by Product
8.4.6.7.4 Rest of LAMEA HPV Testing And Pap Test Market by Technology
8.4.6.7.5 Rest of LAMEA HPV Testing And Pap Test Market by End Use

Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Approvals & Trials:
9.2.5.2 Product Launches and Product Expansions:
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Becton, Dickinson and Company
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Approvals & Trials:
9.5 Hologic, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Approvals & Trials:
9.6 Quest Diagnostics, Incorporated
9.6.1 Company Overview
9.6.2 Financial Analysis
9.7 Qiagen N.V.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.8 Seegene, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Research & Development Expense
9.9 Arbor Vita Corporation
9.9.1 Company Overview
9.10. Femasys, Inc.
9.10.1 Company Overview
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Quest Diagnostics, Incorporated
  • Seegene, Inc.
  • Arbor Vita Corporation
  • Femasys, Inc.
  • Qiagen N.V.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll